|
⚲
|
| Keyboard |
| Buchen David A
✚
|
|
|---|---|
| CIK # | 0001241751 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001241751] | |
| 4 | [0001241751] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Amneal Pharmaceuticals Inc | |
| Buchen David A | |
| Allergan PLC | |
| Watson Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Amneal Pharmaceuticals Inc AMRX
Restricted Stock Units · derivative
|
2020-01-03 | Option exercise | 27,614 | $0.00 | |
|
Amneal Pharmaceuticals Inc AMRX
Class A Common Stock
|
2020-01-03 | Tax withheld | 8,188 | $4.72 | 38,647 |
|
Amneal Pharmaceuticals Inc AMRX
Class A Common Stock
|
2020-01-03 | Option exercise | 27,614 | ||
|
Amneal Pharmaceuticals Inc AMRX
Restricted Stock Units · derivative
|
2019-01-03 | Grant | 110,457 | $0.00 | |
|
Amneal Pharmaceuticals Inc AMRX
Stock Option · derivative
|
2019-01-03 | Grant | 227,273 | $0.00 | |
|
Allergan PLC ACT
Ordinary Shares, par value $0.0001
|
2015-03-05 | Tax withheld | 448 | $295.70 | 132,474 |
|
Allergan PLC ACT
Ordinary Shares, par value $0.0001
|
2015-03-05 | Grant | 3,996 | $0.00 | |
|
Allergan PLC ACT
Ordinary Shares, par value $0.0001
|
2015-03-05 | Tax withheld | 269 | $295.70 | 79,543 |
|
Allergan PLC ACT
Stock Option (Right to Buy) · derivative
|
2014-07-01 | Grant | 22,032 | $0.00 | |
|
Allergan PLC ACT
Performance-Based Restricted Stock Unit · derivative
|
2014-07-01 | Grant | 24,210 | $0.00 | |
|
Allergan PLC ACT
Ordinary Shares, par value $0.0001
|
2014-07-01 | Grant | 7,845 | $0.00 | |
|
Allergan PLC ACT
Ordinary Shares, par value $0.0001
|
2014-05-09 | Grant | 2,960 | $197.05 | 583,268 |
|
Allergan PLC ACT
Ordinary Shares
|
2013-11-11 | Sell | 30,000 | $159.30 | 4,779,000 |
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-10-01 | Disposed to issuer | 89,966 | ||
|
Allergan PLC ACT
Ordinary Shares
|
2013-10-01 | Grant | 89,966 | ||
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-09-30 | Tax withheld | 45,848 | $144.00 | 6,602,112 |
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-09-30 | Grant | 38,441 | ||
|
Watson Pharmaceuticals Inc ACT
Common Stock, par value $0.0033
|
2013-08-29 | Option exercise | 5,000 | $25.64 | 128,200 |
|
Watson Pharmaceuticals Inc ACT
Options to Purchase Common Stock · derivative
|
2013-08-29 | Option exercise | 5,000 | $0.00 | |
|
Watson Pharmaceuticals Inc ACT
Options to Purchase Common Stock · derivative
|
2013-08-29 | Option exercise | 5,000 | $0.00 | |
| showing 20 of 53 most recent transactions | |||||